BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5015143)

  • 1. [Clinical treatment of acute and chronic liver diseases].
    Szabb L
    Z Allgemeinmed; 1972 Feb; 48(4):182-4. PubMed ID: 5015143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience report on Hepavis].
    Menninger U; Menninger W
    Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic results with Hepsan in selected forms of hepatitis].
    Schneider-Reinkens A
    MMW Munch Med Wochenschr; 1977 Jun; 119(25):869-70. PubMed ID: 408608
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 6. [Considerations on the therapy of hepatic steatosis].
    Pisi E; Bianchi FB; Nigro F
    Minerva Med; 1969 Aug; 60(69):3117-32. PubMed ID: 5824710
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ; Borg R
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 10. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 12. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
    Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term therapy of liver diseases].
    Markoff N
    Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glucocorticoids in chronic liver diseases].
    Maier KP; Talke H; Gerok W
    Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic action of S-adenosylmethionine in some chronic hepatopathies].
    Labò G; Gasbarrini GB
    Minerva Med; 1975 May; 66(33):1563-70. PubMed ID: 1143692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various effects of SAM dependent transmethylations in hepatology].
    Labò G; Gasbarrini G; Miglio F
    Minerva Med; 1972 May; 63(35):2007-17. PubMed ID: 5029206
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with a new hepatoprotector].
    Rocca F
    Clin Ter; 1969 Jun; 49(5):473-8. PubMed ID: 5386746
    [No Abstract]   [Full Text] [Related]  

  • 18. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 19. [Searching for a new therapeutic principle. Experience with hepatic therapeutic agent Legalon].
    Schopen RD; Lange OK; Panne C; Kirnberger EJ
    Med Welt; 1969 Apr; 20(15):888-93. PubMed ID: 5784376
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.